BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 31858615)

  • 1. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening.
    Cheng HR; van Vorstenbosch RWR; Pachen DM; Meulen LWT; Straathof JWA; Dallinga JW; Jonkers DMAE; Masclee AAM; Schooten FV; Mujagic Z; Smolinska A
    Clin Transl Gastroenterol; 2022 Nov; 13(11):e00518. PubMed ID: 35981245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
    Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
    Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
    Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of precancerous gastric lesions and gastric cancer through exhaled breath.
    Amal H; Leja M; Funka K; Skapars R; Sivins A; Ancans G; Liepniece-Karele I; Kikuste I; Lasina I; Haick H
    Gut; 2016 Mar; 65(3):400-7. PubMed ID: 25869737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
    van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
    Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breath testing as potential colorectal cancer screening tool.
    Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
    Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection and follow-up of colorectal neoplasia based on faecal volatile organic compounds.
    Bosch S; Bot R; Wicaksono A; Savelkoul E; van der Hulst R; Kuijvenhoven J; Stokkers P; Daulton E; Covington JA; de Meij TGJ; de Boer NKH
    Colorectal Dis; 2020 Sep; 22(9):1119-1129. PubMed ID: 32040880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
    Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
    Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.
    Bond A; Greenwood R; Lewis S; Corfe B; Sarkar S; O'Toole P; Rooney P; Burkitt M; Hold G; Probert C
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1005-1012. PubMed ID: 30828825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
    Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH
    Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study.
    van Lanschot MC; Carvalho B; Coupé VM; van Engeland M; Dekker E; Meijer GA
    BMC Cancer; 2017 Feb; 17(1):116. PubMed ID: 28173852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening with odour material by canine scent detection.
    Sonoda H; Kohnoe S; Yamazato T; Satoh Y; Morizono G; Shikata K; Morita M; Watanabe A; Morita M; Kakeji Y; Inoue F; Maehara Y
    Gut; 2011 Jun; 60(6):814-9. PubMed ID: 21282130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled breath biopsy: a new cancer detection paradigm.
    Abderrahman B
    Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
    [No Abstract]   [Full Text] [Related]  

  • 17. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
    Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel non-invasive colorectal cancer diagnostic method: Volatile organic compounds as biomarkers.
    Alustiza M; Ripoll L; Canals A; Murcia O; Martínez-Roca A; García-Heredia A; Giner-Calabuig M; Jover R; Vidal L
    Clin Chim Acta; 2023 Mar; 542():117273. PubMed ID: 36863694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.